IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

October 9-12, 2019

International Oncolytic Virus 12th Annual Conference

Kah-Whye Peng, Ph.D., Vyriad Chief Technical Officer
Opening Remarks

Stephen Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer
Presentation: “Inflaming tumors with systemic VSV therapy”

Visit event site

Media Inquiries

For inquiries, please contact